| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 04/04/2007 | CN1939434A Quality control of medicine composition |
| 04/04/2007 | CN1939433A Quality control of Chinese medicinal compound preparation |
| 04/04/2007 | CN1939424A Rhizoma corydalis analgetic oral liquid and its preparation |
| 04/04/2007 | CN1939423A Rhizoma corydalis analgetic dispersing tablet |
| 04/04/2007 | CN1939393A Quality control of Chinese-medicine compound preparation |
| 04/04/2007 | CN1939392A Quality control of Chinese medicine compound preparation |
| 04/04/2007 | CN1939391A Quality control of Chinese-medicine compound preparation |
| 04/04/2007 | CN1939390A Medicinal composition and its making method |
| 04/04/2007 | CN1939389A Chinese-medicinal preparation and its making method |
| 04/04/2007 | CN1939372A Quality control of medicine composition |
| 04/04/2007 | CN1939371A Quality control of Chinese-medicinal compound preparation |
| 04/04/2007 | CN1939369A Ginseng saponin drop balls and making method thereof |
| 04/04/2007 | CN1939368A Quality control of Chinese medicinal compound preparation |
| 04/04/2007 | CN1939351A Method for inspecting lucid ganoderma product quality |
| 04/04/2007 | CN1939341A Brain protein hydrolyte freeze-drying preparation for injection and its making method |
| 04/04/2007 | CN1939336A Pharmaceutical agent containing hyaluronan as an active ingredient |
| 04/04/2007 | CN1939323A Bean-curd fruit aglycone preparation and its making method |
| 04/04/2007 | CN1939315A Ganglioside solid lipid nano-particle of monosialic acid tetrahexose and its preparation |
| 04/04/2007 | CN1939309A Alprostadil preparation and its making method |
| 04/04/2007 | CN1939307A 2,4,6-triamino-1,3,5-triazine derivative |
| 04/04/2007 | CN1939279A Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease |
| 04/04/2007 | CN1308438C Compositions including ammonia oxidizing bacteria and methods of using same |
| 04/04/2007 | CN1308329C Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease |
| 04/04/2007 | CN1308325C Novel aryl-{4-halo-4-[heteroarylmethylamino)-methyl]-piperidin-1-yl}-methanone derivatives, methods for production and use thereof as medicaments |
| 04/04/2007 | CN1308324C Quinazoline derivatives as alpha-1 adrenergic antagonists |
| 04/04/2007 | CN1308321C Jujube kernel saponin derivative and its preparation method and use |
| 04/04/2007 | CN1308320C Substituted naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
| 04/04/2007 | CN1308317C New fluorinated benzothiadiazine compounds, a process for their preparation and pharmaceutical compositions containing them |
| 04/04/2007 | CN1308313C Fused azepine drivatives and their use as antidiuretic agents |
| 04/04/2007 | CN1308312C Huperzine B bimolecular and double function group devicative, preparing method and its use |
| 04/04/2007 | CN1308306C 2-aryl-trisubstituted indole acetamide derivative and medicinal use thereof |
| 04/04/2007 | CN1308297C Phenyl sulfamate derivatives |
| 04/04/2007 | CN1308025C Medicine for treating paraplegia and its preparing method |
| 04/04/2007 | CN1308013C Health care capsule for improving sleeping |
| 04/04/2007 | CN1307994C Qilaxitong preparation |
| 04/04/2007 | CN1307993C Macrolides-containing pharmaceutical compositions |
| 04/04/2007 | CN1307988C Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance |
| 04/03/2007 | US7199265 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones |
| 04/03/2007 | US7199239 Chemical compounds |
| 04/03/2007 | US7199152 TNF-α production inhibitor comprising kavalactone as an active ingredient |
| 04/03/2007 | US7199150 Amino alcohol compounds |
| 04/03/2007 | US7199147 Rho kinase inhibitors |
| 04/03/2007 | US7199145 Derivatives of hydantoins, thiohydantoins, pyrimidinediones and thioxopyrimidinones, their preparation processes and their use as medicaments |
| 04/03/2007 | US7199142 1-((5-aryl-1,2,4-oxadiazol-3-yl) benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl) pyrrolidine-3-carboxylates as edg receptor agonists |
| 04/03/2007 | US7199137 Treatment of neurotraumatic diseases, cancer, chronic neurodegeneration, pain, migraine and cardiac hypertrophy |
| 04/03/2007 | US7199133 Antitumor agenst; thrombosis; arteriosclerosis; cardiovascular disorders; antiinflammatory agents |
| 04/03/2007 | US7199132 For therapy of neurodegenerative disease, psychiatric dysfunction, dopamine dysfunction, cocaine abuse and clinical dysfunction |
| 04/03/2007 | US7199130 Substituted 5,6,6a, 11b-tetrahydro-7-oxa-5-aza-benzo[c]fluorene-6-carboxylic acid compounds as NMDA-antagonists |
| 04/03/2007 | US7199129 Derivatives of morphine-like opioid compounds |
| 04/03/2007 | US7199124 Antiinflammatory agents; antiarthritic agents; immunomoderators |
| 04/03/2007 | US7199118 potent and highly efficacious in potentiating AMPA-responses, show good lipophilicity and hence have good physicochemical properties, in particular ability to cross the blood/brain barrier |
| 04/03/2007 | US7199117 2-(substituted phenyl)imidazo[1,2-a]pyridine compounds; use to treat disorders mediated by the histamine H3 receptor such as sleep disorders, attention deficit hyperactivity disorder, and learning and memory disorders; 2-[4-[4-Pyrrolidinobut-1-ynyl]phenyl]-7-methylimidazo[1,2-a]pyridine for example |
| 04/03/2007 | US7199098 Copolymer-1 improvements in compositions of copolymers |
| 04/03/2007 | US7198946 Screening for agents effective in decreasing abnormal macrophages associated with amyotrophic lateral sclerosis |
| 04/03/2007 | US7198911 Identification and cloning of a novel human gene, RET16, involved in the intracellular signaling cascade |
| 04/03/2007 | US7198910 Nucleic acid encoding melanin-concentrating hormone receptor |
| 04/03/2007 | CA2419573C Method of increasing testosterone and related steroid concentrations in women |
| 04/03/2007 | CA2400945C Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof |
| 04/03/2007 | CA2296586C New 2,3-benzodiazepine derivatives |
| 04/03/2007 | CA2289570C 9-azabicyclo(3.3.1)non-2-ene and nonane derivatives as cholinergic ligands at nicotinic ach receptors |
| 04/03/2007 | CA2281918C Oxazolidines as 5-ht2a-antagonists |
| 04/03/2007 | CA2276459C Novel method for testing the differentiation status in pancreatic cells of a mammal |
| 04/03/2007 | CA2236679C Differentiation-suppressive polypeptide |
| 04/03/2007 | CA2236269C Selective .beta.3 adrenergic agonists |
| 04/03/2007 | CA2192822C Use of immunosuppressive agents for the treatment of schizophrenia |
| 04/03/2007 | CA2186601C New combination of a .beta.-receptor blocker and a local anaesthetic |
| 04/03/2007 | CA2176510C Method for preparing concentrated biologically active silicon compounds |
| 04/03/2007 | CA2149044C Use of dimethylbenzofurans and dimethylbenzopyrans as 5-ht3 antagonists |
| 04/03/2007 | CA2108770C Bmp-9 compositions |
| 03/29/2007 | WO2007035542A1 2-HETEROARYL-PYRAZOLO-[4, 3-e]-1, 2, 4-TRIAZOLO-[1,5-c]-PYRIMIDINE AS ADENOSINE A2a RECEPTOR ANTAGONISTS |
| 03/29/2007 | WO2007035322A1 Ryanodine receptor blockers for treating pain |
| 03/29/2007 | WO2007035158A1 Alkyl sulfoxide quinolines as nk-3 receptor ligands |
| 03/29/2007 | WO2007035157A1 Alkylnitrile quinolines, as nk-3 receptor ligands |
| 03/29/2007 | WO2007035156A1 N-oxo-heterocycle and n-oxo-alkyl quinoline-4-carboxamides as nk-3 receptor ligands |
| 03/29/2007 | WO2007035029A1 Pharmaceutical composition for prevention and treatment of drug or alcohol addiction or bipolar disorder using sodium phenylbutyrate |
| 03/29/2007 | WO2007034990A1 Novel combination of drugs as antidepressant |
| 03/29/2007 | WO2007034927A1 Medicine, food and drink or feed containing sphingomyelin |
| 03/29/2007 | WO2007034910A1 Medicinal composition for treating bulimia and depression accompanying bulimia |
| 03/29/2007 | WO2007034778A1 Prophylactic/therapeutic agent for sleep disorder |
| 03/29/2007 | WO2007034757A1 Remedy for amyloid diseases and drug for monitoring the same |
| 03/29/2007 | WO2007034200A1 2-aminoalcohols for the treatment of neurodegenerative diseases |
| 03/29/2007 | WO2007034056A1 ASSOCIATION OF ß3 RECEPTOR AGONIST AND MONOAMINE REUPTAKE INHIBITORS, PHARMACEUTICAL COMPOSITION CONTAINING SAME AND THERAPEUTIC USE THEREOF |
| 03/29/2007 | WO2007034024A2 Treatment of symptoms of parkinson' s disease |
| 03/29/2007 | WO2007033774A2 Use of inhibitors of the na+/h+ exchanger, subtype 5 (nhe5), to improve memory retention |
| 03/29/2007 | WO2007033400A1 Method of treating pain in patients |
| 03/29/2007 | WO2007018738A3 Fused bicycloheterocycle substituted quinuclidine derivatives |
| 03/29/2007 | WO2007014137A3 8-carboxamido-substituted-2 , 6-methano-3-benzazocines and 3 - carboxamido- substituted morphanes as opioid receptor binding agents |
| 03/29/2007 | WO2007012837A3 Compositions for treating psychiatric conditions |
| 03/29/2007 | WO2007011833A3 Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease |
| 03/29/2007 | WO2007010085A3 New pharmaceutical compounds |
| 03/29/2007 | WO2007010085A2 New pharmaceutical compounds |
| 03/29/2007 | WO2007009721A3 Indoline-substituted pyrazoline derivatives, their preparation and use as medicaments |
| 03/29/2007 | WO2007005174A3 4- (3 -hydroxy- and 3-aminomethyl-cyclohexen-3-ylmethyl) 1, 3-dihydroimdazole-2-thione derivatives as alpha-2 adrenergic agonists |
| 03/29/2007 | WO2006132914A3 Cyclobutyl amine derivatives |
| 03/29/2007 | WO2006128911A3 Use of il-18bp isoforms for the treatment and/or prevention of neurological inflammatory diseases |
| 03/29/2007 | WO2006128142A3 Inhibitors of cytosolic phospholipase a2 |
| 03/29/2007 | WO2006123255A3 Substituted oxadiazole derivatives as positive allosteric modulators of metabotropic glutamate receptors |
| 03/29/2007 | WO2006118719A3 Method of improving learning and memory in mammals |
| 03/29/2007 | WO2006109164A3 A method for preventing, delaying or reverting abnormal amyloid deposition |
| 03/29/2007 | WO2006096434A3 Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders |